Showing results (321-330 of 419) with videos related to
Sort By:
Pageof 42
Clinical Genitourinary Cancer|August 4, 2014
MET abnormalities in patients with genitourinary malignancies and outcomes with c-MET inhibitorsDenis L F Jardim, Débora de Melo Gagliato, Gerald Falchook, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 2023
Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in ChondrosarcomaVivek Subbiah, Sant P Chawla, Anthony P Conley, et al.Journal for Immunotherapy of Cancer|September 20, 2019
Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinomaMouhammed Amir Habra, Bettzy Stephen, Matthew Campbell, et al.JCO Precision Oncology|February 9, 2022
Circulating BRAF V600E Cell-Free DNA as a Biomarker in the Management of Anaplastic Thyroid CarcinomaPriyanka C Iyer, Gilbert J Cote, Tao Hai, et al.NPJ Precision Oncology|July 31, 2024
Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterationsSarina A Piha-Paul, Chieh Tseng, Cheuk Hong Leung, et al.Oncotarget|April 21, 2017
Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomasRoman Groisberg, David S Hong, Vijaykumar Holla, et al.Oncotarget|November 21, 2017
Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experienceJennifer B Goldstein, Chad Tang, Kenneth R Hess, et al.BMJ Open|May 2, 2025
A phase I, open-label, multicentre, first-in-human study to evaluate safety, pharmacokinetics and efficacy of AMG 404, a PD-1 inhibitor, in patients with advanced solid tumoursTimothy Price, Iwona Lugowska, Sant P Chawla, et al.Investigational New Drugs|October 28, 2017
Radiomics to predict immunotherapy-induced pneumonitis: proof of conceptRivka R Colen, Takeo Fujii, Mehmet Asim Bilen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2025
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical TrialsJia Liu, Max Farrow, Lesley Seymour, et al.Pageof 42